EAACI Congress 2023
BackUrticaria and angioedema from bench to bedside
Saturday 10 Jun, 12:00 PM -
13:00 PM CEST
Hall Y 05+06
ORAL Session
12:00
Dupilumab Efficacy in Patients With Chronic Spontaneous Urticaria by IgE Level and IgE Over Time: LIBERTY-CSU CUPID Study A
12:12
Barzolvolimab Demonstrates Clinical Activity in a Multiple Ascending Dose Trial in Chronic Spontaneous Urticaria
12:24
Real-world patient burden of hereditary angioedema (HAE) and impact on quality of life (QoL) in regions with limited HAE management options and highest unmet needs
12:36
Effect of recombinant tissue-type plasminogen activator on blood mononuclear cells of patients with alteplase-associated angioedema
12:48
Clinical outcomes and quality of life in patients with HAE receiving lanadelumab long-term prophylaxis: Interim analysis of 3-year real-world data